Long-term follow-up of MCL patients treated with single-agent ibrutinib: updated safety and efficacy results - Publication - Bridge of Knowledge

Your account

login

Search

Long-term follow-up of MCL patients treated with single-agent ibrutinib: updated safety and efficacy results

Abstract

Citations

  • 3 2 8

    CrossRef

  • 0

    Web of Science

  • 3 5 5

    Scopus

Authors (24)

  • Photo of M. Wang

    M. Wang

  • Photo of K. Blum

    K. Blum

  • Photo of P. Martin

    P. Martin

  • Photo of A. Goy

    A. Goy

  • Photo of R. Auer

    R. Auer

  • Photo of B. Kahl

    B. Kahl

  • Photo of W. Jurczak

    W. Jurczak

  • Photo of R. Advani

    R. Advani

  • Photo of J. Romaguera

    J. Romaguera

  • Photo of M. Williams

    M. Williams

  • Photo of J. Barrientos

    J. Barrientos

  • Photo of E. Chmielowska

    E. Chmielowska

  • Photo of J. Radford

    J. Radford

  • Photo of S. Stilgenbauer

    S. Stilgenbauer

  • Photo of M. Dreyling

    M. Dreyling

  • Photo of W. Jedrzejczak

    W. Jedrzejczak

  • Photo of P. Johnson

    P. Johnson

  • Photo of S. Spurgeon

    S. Spurgeon

  • Photo of L. Zhang

    L. Zhang

  • Photo of L. Baher

    L. Baher

  • Photo of M. Cheng

    M. Cheng

  • Photo of D. Lee

    D. Lee

  • Photo of D. Beaupre

    D. Beaupre

  • Photo of S. Rule

    S. Rule

Cite as

Full text

full text is not available in portal

Details

Category:
Magazine publication
Type:
Magazine publication
Published in:
BLOOD no. 126, edition 6, pages 739 - 745,
ISSN: 0006-4971
ISSN:
0006-4971
Publication year:
2015
DOI:
Digital Object Identifier (open in new tab) 10.1182/blood-2015-03-635326
Verified by:
No verification

seen 85 times

Meta Tags